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Introduction. The present study was initiated to investigate the 
cadmium concentrations in whole blood of Northern Sardinian, 
non-occupationally exposed adult subjects. Sardinia is a large 
Italian island which differs genetically and environmentally from 
other mainland Italian areas. 
Methods. Two hundred and forty-three adults (157 females 
and 86 males) were selected in the study area from subjects 
who were undergoing blood collection for laboratory analysis 
during the period January 2005-May 2005. Whole blood was 
analysed by graphite furnace atomic absorption spectrometer 
equipped with a Zeeman-effect background corrector (Perkin 
Elmer ZL5100) and an auto sampler. The adopted analytical 
procedure uses the Stabilized Platform Temperature Furnace 
(STPF) technique. 
Results. The mean value of Blood Cadmium Concentration (BCdC), 
expressed as Geometric Mean, was 0.32 μg/l (CI 95%: 0.31-0.34 
μg/l) significantly ranging from 0.27 μg/l (CI 95%: 0.26-0.29 μg/l) 
in non-smokers to 0.34 μg/l (CI 95%: 0.30-0.39 μg/l) in ex-smokers 
up to 0.47 μg/l (CI 95%: 0.42-0.53 μg/l) in smokers (p < 0.0001). 
Discussion. The results show that BCdC levels in Northern Sar-
dinian non-occupationally exposed adults are lower than levels 
found in many other regions, including those within Italy. Nev-
ertheless, similar values have been detected in other European 
countries and cities.
Conclusions. In relation to other reports in which data were 
analysed by strata for smoking habit and age, we found similar 
BCdC values among non smokers. However, Sardinian smokers 
seem to show lower levels of blood cadmium. 
Introduction
Cadmium (Cd) is a toxic heavy metal which is present 
in the environment. The extremely long biological half 
life (30-35 years) makes it a cumulative toxin [1], so 
long-term past exposure could still result in direct toxic 
effects [2]. 
Even if natural sources of cadmium do exist (volcanic 
activity, forest fires and windblown transport of soil par-
ticles), the main source for the general population consi-
sts of environmental pollution by human activity [3-6]. 
Major occupational exposure occurs in non-ferrous me-
tal smelters, in the production and processing cadmium, 
in the production of Ni-Cd batteries and, increasingly, in 
the recycling of electronic waste [7, 8].
Non-occupational exposure is mainly from cigarette 
smoke, which contains relatively high concentrations 
of the metal; for non-smokers who are not exposed in 
non-occupational activities such as particular hobbies 
(welding, painting, gardening, etc.), diet is the main 
route [3, 9-11]. 
Cadmium has a long biological half-time, and it is 
mainly accumulated in liver and kidneys. IARC, the 
International Agency for Research on Cancer, classified 
cadmium as a carcinogen (group I). Several studies sup-
ported a relationship between cadmium exposure and 
human cancer (lung, kidney, prostate), but an increasing 
number of studies are tending to indicate a likely asso-
ciation with human cancer of the liver, bladder, breast, 
brain and of the haematopoietic system [12-18].
Several studies have shown the relationship between 
chronic exposure to cadmium and blood pressure in ani-
mals and humans [19-21]. The need to determine back-
ground levels of trace elements in biological samples to 
discern possible trends of environmental pollutants on 
human health has been recognised [22].
So far, various studies have been conducted on the con-
centration of Cadmium in whole blood, which is conside-
red a good biomarker and reflects recent exposure to the 
metal under conditions of moderate exposure; while over 
longer periods of time, urine is a preferred biomarker [8].
Regarding Europe, several studies have been made on 
the general population and on particular clusters of re-
sidents, especially in Scandinavia, Germany, Slovenia, 
Spain and the Czech Republic [23-30].
There is also a lot of data from America and Asia, espe-
cially from China and Japan where increased exposure 
has been reported [31-35].
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In Italy, several studies have been carried out in the 
North of the country, while few data are available from 
central and Southern regions. To our knowledge, no 
studies have been performed in the insular region of 
Sardinia [30, 36-38]. Sardinia can be distinguished from 
other Italian regions by characteristics determined by its 
insularity: industrialization is only present in localized 
zones and population differs genetically from that of 
mainland. In fact, Sardinia has long been an object of 
study for particular genetic characteristics which are 
linked or correlated to peculiar diseases, for example 
talassemia, multiple sclerosis and diabetes [39-43].
A study on the concentration of Cadmium in the whole 
blood of residents of Northern Sardinia, who are not 
occupationally exposed, associated to some variables 
such as smoke, age, sex will report the first pattern on 
cadmium exposure of the general population in this area 
and could represent a source of useful data both for 
preventive purposes and for future research in medical 
fields. 
Materials and methods 
SUBJECTS AND AREA
The present study was performed in the health district of 
Sassari, an area in Northern Sardinia with approximately 
340,000 inhabitants. It is well known that the Sardinian 
population has a genetic background very different to 
the rest of Italy and all known European and African 
populations [44]. The Sardinian population is geneti-
cally quite homogeneous and because of its insularity, 
external influence in term of migratory flux is moderate, 
making it well adapted for epidemiological purposes. 
Two hundred and forty-three adults (157 females and 
86 males) were selected in the study area from subjects 
who were undergoing blood collection for laboratory 
analysis during the period January 2007-May 2007. 
The mean age was 50.0 years (standard deviation 18.6). 
There were 143 non-smokers, 39 ex-smokers (i.e., 
smokers which have stopped smoking for 6 months) 
and 61 current smokers. The exclusion criteria were: 
age under 18 years and/or a high exposure to cadmium 
related to occupation or hobby. Subjects were enrolled 
as participants in the study only after they had yielded 
informed consent to participate. 
An anonymous questionnaire for each participant was 
compiled concerning demographic characteristics, resi-
dence in the last 15 years, occupation, hobbies, diet and 
smoking habit. 
SAMPLING AND ANALYSIS
For cadmium determination, a venous blood sample of 
5 ml at fasting was collected in EDTA-containing tubes. 
Blood samples, with identification numbers correspond-
ing to the same questionnaires, were immediately frozen 
at –20°C in Nunc crio-vials until analysis. 
Cadmium measurements were performed by graphite 
furnace atomic absorption spectrometer equipped with 
a Zeeman-effect background corrector (Perkin Elmer 
ZL5100) and a auto sampler. The adopted analytical 
procedure uses the Stabilized Platform Temperature 
Furnace (STPF) technique. 
Samples to be analysed were withdrawn from the re-
frigerator and kept overnight at room temperature. One 
hundred microliters aliquots of each blood sample were 
added to 900 μl of an aqueous solution containing 0.01% 
Triton X-100, and carefully mixed in clean metal-free 
plastic tubes. The solutions were then transferred into 
the vials of the auto sampler. Chemical modifier solu-
tion was prepared by mixing 2000 mg.l–1 of NH4H2PO4 and 207 mg.l–1 di Mg(NO3)26H2O. Five microliters of this solution were added to every aliquot of measure-
ment solution in the graphite tube. 
The instrumental method required that two aliquots of 
sample (20 μl) and two aliquots of chemical modifier 
solution (5 μl) were added to the furnace. After each 
sample introduction, a dried step was performed. This 
step allows an increase in the amount of sample ana-
lysed and improves the detection limit. Determinations 
of cadmium were performed by interpolation of the 
sample peak area with a calibration curve. Calibration 
was carried out by using aqueous solution of cadmium 
at the following concentrations: 0.02, 0.04 and 0.08μg/l. 
The working solutions, containing 0.01% Triton X-100, 
were prepared daily. 
The regression equation was calculated using un-
weighted least squares regression analysis. The curve 
parameters were: slope, b = 0.177 ± 0.005; intercept, 
a = –0.0002 ± 0.0002; determination coefficient, 
r2 = 0.998. The calibration curve passes through the 
origin of the axis.
The limit of detection (LoD) was 0.05 μg/l, evaluated 
with the Upper Limit Approach (ULA2) related to the 
calibration curve.
Reliability estimation method was performed by analys-
ing two incurred blood samples at a Cadmium concen-
tration of 0.30 μg/l and 0.67 μg/l (expressed as mean 
value). The replicates, six for each sample, provide the 
following coefficients of variation: 17% for the sample 
at 0.30 μg/l and 12% for the sample at 0.67 μg/l. The 
accuracy of the method was assessed against the certi-
fied reference material BCR 194, purchased from Com-
munity Bureau of Reference, Brussels, Belgium, with 
certified Cadmium concentration of 0.20 μg/l ± 0.05 
μg/l. The mean value obtained, with six replicates, was 
0.25 μg/l (SD, 0.01 μg/l). All materials employed in 
collection, storing and analysis of blood samples were 
of the highest quality and certificated. Water was deion-
ized and then further purified with a Milli-Q system 
(Millipore). Collection tubes were warmed up with a 
nitric acid solution wash.
STATISTICAL METHODS
Statistical analysis was performed using Stata 9® [45]. 
Do to the asymmetric distribution of data, a log trans-
formation was applied. Confidence Intervals (CI 95%) 
for geometric mean (GM) were calculated according to 
the appropriate t distribution degrees of freedom. Differ-
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ences among groups were tested via variance analysis. 
A linear regression model was also applied to study 
dependence of blood cadmium concentration (BCdC) 
on explicative variables. The median and percentiles of 
BCdC were also calculated. A p-value of < 0.05 (two 
tails) was chosen to indicate statistical significance; 
if statistical test did not reach significance, a “NS” 
response (Not Significant) was set. Participants were 
grouped into categories of age: < 40 i.e., 18 to 39 years, 
40-59 i.e., 40 to 59 years and > 59 i.e., over 59 years 
old. Smoking history was grouped into three categories: 
non-smokers, ex-smokers and smokers. Smokers were 
further classified as light smokers (1-10 cigarettes/day), 
moderate smokers (11-20 cigarettes/day) and heavy 
smokers (> 20 cigarettes/day).
Results
The distribution of data was considerably asymmetric 
(Fisher’s γ1: 1.51) and log transformation was able to make it symmetric (Fisher’s γ1: 0.15). The BCdC ranged from 0.10 μg/l to 1.2 μg/l. 
Table I reports the distribution of BCdC by smoking 
habit. One hundred forty-three subjects (58.8%) were 
non-smokers, 39 (16.1%) were ex-smokers and 61 were 
smokers (25.1%). The overall geometric mean (GM) of 
BCdC was 0.32 μg/l (CI 95%: 0.31-0.34 μg/l) signifi-
cantly ranging (ANOVA: p < 0.0001) from 0.27 μg/l (CI 
95%: 0.26-0.29 μg/l) in non-smokers to 0.34 μg/l (CI 
95%: 0.30-0.39 μg/l) in ex-smokers up to 0.47 μg/l (CI 
95%: 0.42-0.53 μg/l) in smokers. Because of the effi-
ciency of log transformation the median values of BCdC 
in the whole set (0.31 μg/l) and in specific subgroups 
by smoking habit (0.27, 0.33, 0.50 μg/l, respectively) 
are similar to GM ones. The increasing trend detected 
in BCdC-GMs and in BCdC-median values through the 
three categories of non-smokers, ex-smokers and smok-
ers was also observed in percentile values. 
No significant differences in BCdC-GMs between 
genders (males: GM = 0.33 μg/l; CI95%: 0,29-0.36; 
females: GM = 0.32 μg/l; CI 95%: 0.30-0.34) were 
detected. Slightly higher values were detected in non-
smoker and ex-smoker females, but not in smokers 
where males seem to have higher values (Tab. II). 
Moreover, the increasing trend through the three cat-
egories of smoking habits was observed in both sexes 
(p < 0.0001). 
On the whole, no significant differences in BCdC-GMs 
were observed among categories of age (Tab. III). 
However, when data were stratified by smoking habit, 
significant differences by age arose in non-smokers 
(p < 0.05). In that category, BCdC resulted depending 
on age (linear regression of log-values: intercept = –
1,60, coeff. B = 0,0061; p < 0,001) (Tab. IV). Neverthe-
less significant differences (p < 0.0001) were observed 
in mean age among categories of smoking habit (Tab. 
V), with ex-smokers the oldest group (59.5 ± 16.2) and 
smokers the youngest (43.4 ± 13.8). Table VI reports 
the distribution of BCdC-GMs in smokers by number of 
cigarettes/day. As expected, an increase in BCdC-GMs 
was observed among categories of smokers with values 
ranging from 0.44 μg/l in light smokers (CI 95%: 0.38-
0.49 μg/l) to 0.48 μg/l in moderate smokers (CI 95%: 
Tab. I. BCdC (μg/l) in relation to smoking habit.
Smoking habit 95% GM-CI
N GM* lower upper Median p5 p25 p75 p95
Non-smokers 143 0.27 0.26 0.29 0.27 0.13 0.21 0.36 0.53
Ex-smokers 39 0.34 0.30 0.39 0.33 0.20 0.26 0.42 0.61
Smokers 61 0.47 0.42 0.53 0.50 0.21 0.38 0.61 0.86
Total 243 0.32 0.31 0.34 0.31 0.15 0.24 0.45 0.74
N: sample size; GM: geometric mean; 95% GM-CI: confidence interval for GM; p5, p25, p75, p95: percentiles; * significant parameter: analysis of vari-
ance p < 0.0001.
Tab. II. BCdC (μg/l) in relation to gender and smoking habit.
Males Females
Smoking habit 95% GM-CI 95% GM-CI p
N GM* lower upper N GM* lower upper
Non-smokers 34 0.25 0.22 0.28 109 0.28 0.26 0.31 NS
Ex-smokers 22 0.32 0.27 0.39 17 0.36 0.30 0.43 NS
Smokers 30 0.47 0.41 0.55 31 0.44 0.35 0.55 NS
Total 86 0.33 0.29 0.36 157 0.32 0.30 0.34 NS
N: sample size; GM: geometric mean; 95% GM-CI: confidence interval for GM; NS: not significant (p > 0.05); * significant parameter: analysis of variance 
p < 0.0001.
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0.40-0.57 μg/l) up to 0.64 μg/l in heavy smokers (CI 
95%: 0.50-0.80 μg/l), although these differences were 
not significant because of the small size of the last cat-
egory (p = 0.16).
Discussion
The results of the present study, concerning BCdC in 
general adult population not occupationally exposed 
residing in Northern Sardinia (overall GMs 0.32 μg/l, 
ranging from 0.10 μg/l to 1.20 μg/l), show that the 
BCdC is lower than levels reported in other Italian 
populations [30, 36, 37] which ranged between 0.5 μg/l 
to 0.7 μg/l. Higher values were also detected in Euro-
pean regions [25, 26, 28, 46] and in Asia, particularly 
in Japan [31, 35]. Nevertheless similar values have been 
detected in other European countries and cities [24, 47] 
and in Asia, where in Singapore it ranges from 0.21 μg/l 
to 0.49μg/l [33]. The BCdC results depend on smoking 
habit, with increasing levels both through overall ordinal 
categories (from non-smokers to smokers) and through 
specific ones (from light smokers to heavy smokers). 
These results in non-smokers (0.27 μg/l), in ex-smok-
ers (0.34 μg/l) and in smokers (0.47 μg/l), with a level 
about two times higher in the latter category compared 
to the first one, emphasize the role of cigarette smoking 
in enhancing BCdC. This finding, in accordance with 
other reports [3, 25, 36, 48-50] shows that alongside di-
et, cigarette smoking is the most important behavioural 
determinant for BCdC in non-occupationally exposed 
population. Moreover, this figure is confirmed in our 
study by the increasing BCdCs detected in smokers re-
garding consumption of cigarettes per day: 0.44 μg/l in 
light smokers, 0.48 μg/l in moderate smokers and 0.64 
μg/l in heavy smokers. Several studies report similar 
data [3, 36] even if conflicting results are reported: in 
the Singaporeon study, where BCdC was analyzed in 
three ethnic groups, in Chinese group non-smokers had 
higher concentration than light and moderate smokers: 
0.15 μg/l, 0.10 μg/l and 0.10 μg/l, respectively [33]. 
Furthermore, in our study, there was a non-homogene-
ous distribution of data set by age and smoking habit, 
as smokers were significantly younger than other cat-
egories, and an early initiation of smoking was found in 
Sardinian people [51, 52]. The possible additive effect 
of cadmium accumulation by age might have interfered 
with smoking habit; in fact, we found that BCdCs 
depend on age in non-smokers (linear regression: 
p < 0.001) but not in the categories of ex-smokers and 
smokers, where the effect of cigarette smoking hides 
that of the age. Thus, the unbalanced distribution of the 
sample by age and categories of smokers triggers off an 
overall slight increase of BCdCs with age. 
Gender doesn’t seem to be a contributing factor 
for BCdCs, 0.33 μg/l in males and 0.32 μg/l in fe-
males, as has also been reported in several other 
studies [26, 28], although we found a moderate but 
not significantly higher BCdC-GMs in non-smoking 
and former smoker women, as already described in 
Sweden [3]. On the other hand, in Morocco, it was 
reported that cadmium concentration in men was 30% 
higher than in women overall [49] and similar results 
were found in Northern Italy [30]. On the whole, even 
if it has been reported that cadmium exposure may 
influence mortality in gender [53], we believe that 
gender is not a true determinant for BCdCs and the 
conflicting results obtained in different reports may 
depend on confounding.
In conclusion, overall BCd levels in Northern Sardin-
ian non-occupationally exposed people were lower than 
Tab. IV. Regression model for log-trasformed BCdC in non smokers.
95% Confidence Intervals
Variable Coeff. Std. Err. t-value p-value Lower Upper
Age 0.0061 0.0017 3.60 0.000 0.0027 0.0094
Constant –1.6011 0.0910 –17.60 0.000 –1.7810 –1.4214
Model R-squared = 0.08.
Tab. V. Age in relation to smoking habit.
Age*
Smoking habit N GM* Mean St. dev.
Non-smokers 143 0.27 50.0 20.0
Ex-smokers 39 0.34 59.5 16.2
Smokers 61 0.47 43.4 13.8
Total 243 0.32 49.9 18.7
* significant parameter: analysis of variance p < 0.0001. 
Tab. VI. Distribution of BCdC-GMs (μg/l) in smokers, classified 
by number of smoked cigarettes/day
Category of 
smokers, 
n. cigarettes/day
95% Confidence 
Intervals
N GM lower upper
Light, 1-10 24 0.44 0.38 0.49
Moderate, 11-20 31 0.48 0.40 0.57
Heavy, > 20 6 0.64 0.50 0.80
Total 61
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many other areas. Nevertheless, this aggregate result 
may be affected by a non-homogeneous distribution of 
the sample by strata of behavioural variables referring 
to other studies. In fact, in relation to other reports, 
when data were analysed by strata for smoking habit 
and age we found similar values among non smokers, 
but Northern Sardinian smokers seem to show lower 
levels of blood cadmium. In part, these results may re-
flect short-term exposure since we used blood instead of 
urine concentration as a biomarker, whereas urine is the 
preferred biomarker for long-term exposure. 
These low values may be explained in part by environ-
mental factors considering that the study was conducted 
in an area at low risk from industrial cadmium fall-out. 
Nevertheless, in view of the peculiar characteristics of 
the Sardinian population, other factors that may influ-
ence BCd levels, like dietary and genetic factors [33], 
could be further investigated. 
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